These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2099757)

  • 1. Is there a need to reclassify adult rheumatoid arthritis?
    Buchanan WW; Singal DP
    Br J Rheumatol; 1990 Oct; 29(5):377-81. PubMed ID: 2099757
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphism of major histocompatibility complex extended haplotypes bearing HLA-DR3 in patients with rheumatoid arthritis with gold induced thrombocytopenia or proteinuria.
    Singal DP; Reid B; Green D; D'Souza M; Bensen WG; Buchanan WW
    Ann Rheum Dis; 1990 Aug; 49(8):582-6. PubMed ID: 2396862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA.
    Singal DP; Green D; Reid B; Gladman DD; Buchanan WW
    Ann Rheum Dis; 1992 Jan; 51(1):23-8. PubMed ID: 1371662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DR antigens and proteinuria induced by aurothioglucose and D-penicillamine in patients with rheumatoid arthritis.
    Speerstra F; Reekers P; van de Putte LB; Vandenbroucke JP; Rasker JJ; de Rooij DJ
    J Rheumatol; 1983 Dec; 10(6):948-53. PubMed ID: 6420562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA associations in aurothioglucose- and D-penicillamine-induced haematotoxic reactions in rheumatoid arthritis.
    Speerstra F; Reekers P; van de Putte LB; Vandenbroucke JP
    Tissue Antigens; 1985 Jul; 26(1):35-40. PubMed ID: 3929421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seronegative rheumatoid arthritis and HLA-DR4.
    al-Jarallah KF; Buchanan WW; Sastry A; Singal DP
    J Rheumatol; 1994 Feb; 21(2):190-3. PubMed ID: 8182622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A DR4-associated DR-DQ haplotype is significantly associated with rheumatoid arthritis.
    Wallin J; Carlsson B; Ström H; Möller E
    Arthritis Rheum; 1988 Jan; 31(1):72-9. PubMed ID: 2830890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheumatoid factor negative (seronegative) rheumatoid arthritis: evolving clinical classification and immunogenetic associations.
    Masi AT
    J Rheumatol; 1988 Jan; 15(1):4-6. PubMed ID: 3258383
    [No Abstract]   [Full Text] [Related]  

  • 9. A systematic survey of HLA-A,B,C and D antigens and drug toxicity in rheumatoid arthritis.
    Dequeker J; Van Wanghe P; Verdickt W
    J Rheumatol; 1984 Jun; 11(3):282-6. PubMed ID: 6376799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seronegative rheumatoid arthritis: tell it as it is.
    Buchanan WW; Singal DP
    J Rheumatol; 1994 Mar; 21(3):391-3. PubMed ID: 8006880
    [No Abstract]   [Full Text] [Related]  

  • 11. HLA-DR antigens and HLA-DQ beta chain polymorphism in susceptibility to rheumatoid arthritis.
    Ilonen J; Reijonen H; Arvilommi H; Jokinen I; Möttönen T; Hannonen P
    Ann Rheum Dis; 1990 Jul; 49(7):494-6. PubMed ID: 1974413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HLA-DQ7 and -DQ8 associations in DR4-positive rheumatoid arthritis patients. A combined analysis of data available in the literature.
    Fugger L; Svejgaard A
    Tissue Antigens; 1997 Nov; 50(5):494-500. PubMed ID: 9389324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
    Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ
    J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens.
    Moens HJ; Ament BJ; Feltkamp BW; van der Korst JK
    J Rheumatol; 1987 Dec; 14(6):1115-9. PubMed ID: 3437418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-D antigens in rheumatoid arthritis and toxicity to gold and penicillamine.
    Nuotio P; Nissilä M; Ilonen J
    Scand J Rheumatol; 1986; 15(3):255-8. PubMed ID: 3492038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA DR antigens in rheumatoid arthritis.
    Gran JT; Husby G; Thorsby E
    Scand J Rheumatol; 1983; 12(3):241-5. PubMed ID: 6604939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.
    Stockman A; Zilko PJ; Major GA; Tait BD; Property DN; Mathews JD; Hannah MC; McCluskey J; Muirden KD
    J Rheumatol; 1986 Apr; 13(2):269-73. PubMed ID: 3459889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis.
    Bensen WG; Moore N; Tugwell P; D'Souza M; Singal DP
    J Rheumatol; 1984 Jun; 11(3):358-61. PubMed ID: 6234391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement C4 null alleles as a marker of gold or D-penicillamine toxicity in the treatment of rheumatoid arthritis.
    Clarkson RW; Sanders PA; Grennan DM
    Br J Rheumatol; 1992 Jan; 31(1):53-4. PubMed ID: 1730108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential associations of HLA-DR antigens with rheumatoid arthritis (RA) in Basques: high frequency of DR1 and DR10 and lack of association with HLA-DR4 or any of its subtypes.
    de Juan MD; Belmonte I; Barado J; Martinez Laso J; Figueroa M; Arnaiz-Villena A; Cuadrado E
    Tissue Antigens; 1994 May; 43(5):320-3. PubMed ID: 7940501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.